Cargando…

Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma

PURPOSE: Allergen immunotherapy (AIT), when continued for 3 years, is the only disease-modifying treatment for AR and asthma. Adherence is a key to ensure effectiveness, and poor adherence is a contraindication for AIT. The objective of this study was to evaluate real-world adherence to AIT with sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogelberg, Christian, Brüggenjürgen, Bernd, Richter, Hartmut, Jutel, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231771/
https://www.ncbi.nlm.nih.gov/pubmed/32494127
http://dx.doi.org/10.2147/PPA.S242957
_version_ 1783535247983378432
author Vogelberg, Christian
Brüggenjürgen, Bernd
Richter, Hartmut
Jutel, Marek
author_facet Vogelberg, Christian
Brüggenjürgen, Bernd
Richter, Hartmut
Jutel, Marek
author_sort Vogelberg, Christian
collection PubMed
description PURPOSE: Allergen immunotherapy (AIT), when continued for 3 years, is the only disease-modifying treatment for AR and asthma. Adherence is a key to ensure effectiveness, and poor adherence is a contraindication for AIT. The objective of this study was to evaluate real-world adherence to AIT with subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) preparations in patients allergic to grass or tree pollen. The impact of AIT on the consumption of asthma and rhinitis medication was also analyzed. PATIENTS AND METHODS: In this retrospective cohort analysis of a German longitudinal prescription database, the adherence of a grass and tree pollen allergoid was examined and compared to two sublingual AIT tablets/drops. Patients receiving grass or tree allergen-specific immunotherapy prescriptions were compared with non-AIT patients receiving symptomatic allergic rhinitis (AR) and asthma prescriptions. The study endpoints included therapy adherence, AR progression, and asthma progression. Multivariate regression analyses were used to estimate the effects of SCIT or SLIT, adjusting for variables related to demographics and prescriptions. RESULTS: SCIT adherence was 60.1–61.8% at 2 years and 35.0–37.5% at 3 years for the two allergens. SLIT adherence was distinctly lower (29.5–36.5% and 9.6–18.2%, respectively). Adherence in children was higher compared to adolescents or adults. All products were highly efficacious at reducing symptomatic AR medication consumption. SCIT also reduced asthma medication use for both allergens, whereas for SLIT these results were significant only for grasses but not trees. CONCLUSION: Subcutaneous AIT in a real-world setting achieved significantly higher adherence rates compared to sublingual administration. SCIT reduced the use of rhinitis and asthma medication significantly for both allergens, while SLIT reduced the use of rhinitis medication for both allergens and the use of asthma medication for grasses only.
format Online
Article
Text
id pubmed-7231771
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72317712020-06-02 Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma Vogelberg, Christian Brüggenjürgen, Bernd Richter, Hartmut Jutel, Marek Patient Prefer Adherence Original Research PURPOSE: Allergen immunotherapy (AIT), when continued for 3 years, is the only disease-modifying treatment for AR and asthma. Adherence is a key to ensure effectiveness, and poor adherence is a contraindication for AIT. The objective of this study was to evaluate real-world adherence to AIT with subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) preparations in patients allergic to grass or tree pollen. The impact of AIT on the consumption of asthma and rhinitis medication was also analyzed. PATIENTS AND METHODS: In this retrospective cohort analysis of a German longitudinal prescription database, the adherence of a grass and tree pollen allergoid was examined and compared to two sublingual AIT tablets/drops. Patients receiving grass or tree allergen-specific immunotherapy prescriptions were compared with non-AIT patients receiving symptomatic allergic rhinitis (AR) and asthma prescriptions. The study endpoints included therapy adherence, AR progression, and asthma progression. Multivariate regression analyses were used to estimate the effects of SCIT or SLIT, adjusting for variables related to demographics and prescriptions. RESULTS: SCIT adherence was 60.1–61.8% at 2 years and 35.0–37.5% at 3 years for the two allergens. SLIT adherence was distinctly lower (29.5–36.5% and 9.6–18.2%, respectively). Adherence in children was higher compared to adolescents or adults. All products were highly efficacious at reducing symptomatic AR medication consumption. SCIT also reduced asthma medication use for both allergens, whereas for SLIT these results were significant only for grasses but not trees. CONCLUSION: Subcutaneous AIT in a real-world setting achieved significantly higher adherence rates compared to sublingual administration. SCIT reduced the use of rhinitis and asthma medication significantly for both allergens, while SLIT reduced the use of rhinitis medication for both allergens and the use of asthma medication for grasses only. Dove 2020-05-13 /pmc/articles/PMC7231771/ /pubmed/32494127 http://dx.doi.org/10.2147/PPA.S242957 Text en © 2020 Vogelberg et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Vogelberg, Christian
Brüggenjürgen, Bernd
Richter, Hartmut
Jutel, Marek
Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
title Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
title_full Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
title_fullStr Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
title_full_unstemmed Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
title_short Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
title_sort real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231771/
https://www.ncbi.nlm.nih.gov/pubmed/32494127
http://dx.doi.org/10.2147/PPA.S242957
work_keys_str_mv AT vogelbergchristian realworldadherenceandevidenceofsubcutaneousandsublingualimmunotherapyingrassandtreepolleninducedallergicrhinitisandasthma
AT bruggenjurgenbernd realworldadherenceandevidenceofsubcutaneousandsublingualimmunotherapyingrassandtreepolleninducedallergicrhinitisandasthma
AT richterhartmut realworldadherenceandevidenceofsubcutaneousandsublingualimmunotherapyingrassandtreepolleninducedallergicrhinitisandasthma
AT jutelmarek realworldadherenceandevidenceofsubcutaneousandsublingualimmunotherapyingrassandtreepolleninducedallergicrhinitisandasthma